New Drug for Seriously Ill COVID-19 Patients Shows Promise Under Right to Try Act

New information collected under the federal Right to Try Act shows promise for the new drug ZYESAMI, now in clinical trials for the treatment of serious cases of COVID-19. The information was collected by a hospital in the U.S. southwest, drug developer NRx announced in a news release Jan. 26.

I checked with both the Charlotte Lozier Institute and Children of God for Life and they have no listing for the drug with regards to whether or not it is abortion tainted.

Recent Posts

See All